Coloplast A

Company Profile

Coloplast A had its IPO on under the ticker symbol CLPBY.

The company operates in the Healthcare sector and Medical Instruments & Supplies industry. Coloplast A has a staff strength of 14,500 employees.

Stock update

Shares of Coloplast A opened at $13.05 at the start of the last trading session i.e. 2023-03-31.

The stocks traded within a range of $13.05 - $13.2, and closed at $13.14.

This is a +2.99% increase from the previous day's closing price.

A total volume of 50,245 shares were traded at the close of the day’s session.

In the last one week, shares of Coloplast A have increased by +8.87%.

Coloplast A's Key Ratios

Coloplast A has a market cap of $28.70 billion, indicating a price to book ratio of 22.4646 and a price to sales ratio of 1.1347.

In the last 12-months Coloplast A’s revenue was $23.52 billion with a gross profit of $15.53 billion and an EBITDA of $7.76 billion. The EBITDA ratio measures Coloplast A's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, Coloplast A’s operating margin was 29.97% while its return on assets stood at 17.14% with a return of equity of 75.07%.

In Q4, Coloplast A’s quarterly earnings growth was a negative -6.3% while revenue growth was a positive 18.1%.

Coloplast A’s PE and PEG Ratio

Forward PE

33.3333

Trailing PE

42.3871

PEG

3.3942

Its diluted EPS in the last 12-months stands at $0.31 per share while it has a forward price to earnings multiple of 33.3333 and a PEG multiple of 3.3942. A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Coloplast A’s profitability.

Coloplast A stock is trading at a EV to sales ratio of 1.2771 and a EV to EBITDA ratio of 3.9889. Its price to sales ratio in the trailing 12-months stood at 1.1347.

Coloplast A stock pays annual dividends of $20 per share, indicating a yield of 2.21% and a payout ratio of 86.53%.

Balance sheet and cash flow metrics

Total Assets

$35.22 billion

Total Liabilities

$10.48 billion

Operating Cash Flow

$0

Capital Expenditure

$275 million

Dividend Payout Ratio

86.53%

Coloplast A ended 2023 with $35.22 billion in total assets and $0 in total liabilities. Its intangible assets were valued at $35.22 billion while shareholder equity stood at $5.91 billion.

Coloplast A ended 2023 with $0 in deferred long-term liabilities, $10.48 billion in other current liabilities, 216000000.00 in common stock, $6.45 billion in retained earnings and $0 in goodwill. Its cash balance stood at $671.00 million and cash and short-term investments were $881.00 million. The company’s total short-term debt was $5,168,000,000 while long-term debt stood at $16.36 billion.

Coloplast A’s total current assets stands at $9.28 billion while long-term investments were $0 and short-term investments were $210.00 million. Its net receivables were $3.95 billion compared to accounts payable of $964.00 million and inventory worth $3.40 billion.

In 2023, Coloplast A's operating cash flow was $0 while its capital expenditure stood at $275 million.

Comparatively, Coloplast A paid $0.87 in dividends in 2023.

Other key metrics

Current Trading Price

$13.14

52-Week High

$15.564

52-Week Low

$9.6126

Analyst Target Price

$

Coloplast A stock is currently trading at $13.14 per share. It touched a 52-week high of $15.564 and a 52-week low of $15.564. Analysts tracking the stock have a 12-month average target price of $.

Its 50-day moving average was $11.9 and 200-day moving average was $11.43 The short ratio stood at 0 indicating a short percent outstanding of 0%.

Around 0% of the company’s stock are held by insiders while 1.6% are held by institutions.